Conn. Jury Hands Boehringer 3rd Straight Pradaxa Trial Win
Boehringer Ingelheim Pharmaceuticals has won its third straight bellwether trial over the alleged bleeding risk of its blood thinner Pradaxa, after a Connecticut state jury rejected a man's claims that the...To view the full article, register now.
Already a subscriber? Click here to view full article